Ranger Investment Management, L.P. Fulgent Genetics, Inc. Transaction History

Ranger Investment Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $8.75 Million - $13.2 Million	-130,944 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $2.27 Million - $7.04 Million	-38,290 Reduced 22.63%	130,944 $12.7 Million
Q4 2020 Feb 12, 2021	SELL	$31.01 - $52.1 $3.36 Million - $5.64 Million	-108,323 Reduced 39.03%	169,234 $8.82 Million
Q3 2020 Nov 16, 2020	SELL	$15.89 - $50.51 $1.88 Million - $5.98 Million	-118,367 Reduced 29.9%	277,557 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$8.89 - $18.28 $608,209 - $1.25 Million	68,415 Added 20.89%	395,924 $6.34 Million
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $1.8 Million - $5.26 Million	266,351 Added 435.51%	327,509 $3.52 Million
Q4 2019 Feb 14, 2020	BUY	$9.29 - $15.82 $568,157 - $967,519	61,158 New	61,158 $789,000

198

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $504M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ranger Investment Management, L.P. with notifications on news.